s5ogsswm | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/s5ogsswm_hasAnnotation_C0013227> <https://research.tib.eu/covid-19/entity/s5ogsswm_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Campesi%2C_Ilaria%3B_Montella%2C_Andrea%3B_Franconi_F%2C_Flavia>
?:doi	10.1016/j.phrs.2020.105285
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.phrs.2020.105285>
?:journal	Pharmacol_Res
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/b18293f4e4c9deeeaf815bd748c7fadbae0ae799.json
?:pmc_json_files	document_parses/pmc_json/PMC7641521.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7641521>
?:pmid	<https://research.tib.eu/covid-19/entity/33160068.0>
?:pmid	33160068.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/b18293f4e4c9deeeaf815bd748c7fadbae0ae799>
?:source	Elsevier; Medline; PMC
?:title	Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-04

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/s5ogsswm>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/s5ogsswm>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all